Conflicts and Contradictions in Current Skin Cancer Screening Guidelines

K. Y. Wojcik, L. A. Escobedo, K. A. Miller, M. Hawkins, O. Ahadiat, S. Higgins, Ashley Wysong, Myles Cockburn

Research output: Contribution to journalReview article

Abstract

Purpose of Review: The purpose of this paper is to review skin cancer screening guidelines from major public health/medical organizations. Recent Findings: No consensus exists on whether or not screening to prevent skin cancer is warranted. Summary: The best evidence of screening efficacy should come from population-based randomized trials, but is unlikely to exist due to feasibility constraints. Consequently, consensus should be built from observational/non-randomized designs, such as the SCREEN study in Germany. Current guidelines often focus on melanoma alone, while potential benefits of screening for non-melanoma skin cancers (NMSC) are largely overlooked. There may be less room for doubt regarding the value of screening, if both diseases were considered. Further, targeted approaches, i.e., screening only in high-risk populations, remain poorly defined and untested. Continuing to state that there is insufficient evidence to recommend screening leads to confusion about whether or not to screen and is unlikely to result in substantial changes to the morbidity of NMSC and significant mortality from melanoma.

Original languageEnglish (US)
Pages (from-to)316-324
Number of pages9
JournalCurrent Dermatology Reports
Volume6
Issue number4
DOIs
StatePublished - Dec 1 2017

Fingerprint

Skin Neoplasms
Early Detection of Cancer
Guidelines
Melanoma
Population
Germany
Public Health
Organizations
Morbidity
Mortality

Keywords

  • Guidelines
  • Recommendations
  • Review
  • Screening
  • Skin cancer
  • Skin examination

ASJC Scopus subject areas

  • Dermatology

Cite this

Wojcik, K. Y., Escobedo, L. A., Miller, K. A., Hawkins, M., Ahadiat, O., Higgins, S., ... Cockburn, M. (2017). Conflicts and Contradictions in Current Skin Cancer Screening Guidelines. Current Dermatology Reports, 6(4), 316-324. https://doi.org/10.1007/s13671-017-0205-6

Conflicts and Contradictions in Current Skin Cancer Screening Guidelines. / Wojcik, K. Y.; Escobedo, L. A.; Miller, K. A.; Hawkins, M.; Ahadiat, O.; Higgins, S.; Wysong, Ashley; Cockburn, Myles.

In: Current Dermatology Reports, Vol. 6, No. 4, 01.12.2017, p. 316-324.

Research output: Contribution to journalReview article

Wojcik, KY, Escobedo, LA, Miller, KA, Hawkins, M, Ahadiat, O, Higgins, S, Wysong, A & Cockburn, M 2017, 'Conflicts and Contradictions in Current Skin Cancer Screening Guidelines', Current Dermatology Reports, vol. 6, no. 4, pp. 316-324. https://doi.org/10.1007/s13671-017-0205-6
Wojcik KY, Escobedo LA, Miller KA, Hawkins M, Ahadiat O, Higgins S et al. Conflicts and Contradictions in Current Skin Cancer Screening Guidelines. Current Dermatology Reports. 2017 Dec 1;6(4):316-324. https://doi.org/10.1007/s13671-017-0205-6
Wojcik, K. Y. ; Escobedo, L. A. ; Miller, K. A. ; Hawkins, M. ; Ahadiat, O. ; Higgins, S. ; Wysong, Ashley ; Cockburn, Myles. / Conflicts and Contradictions in Current Skin Cancer Screening Guidelines. In: Current Dermatology Reports. 2017 ; Vol. 6, No. 4. pp. 316-324.
@article{d0e03dfb6f694dedab052861a2812d7b,
title = "Conflicts and Contradictions in Current Skin Cancer Screening Guidelines",
abstract = "Purpose of Review: The purpose of this paper is to review skin cancer screening guidelines from major public health/medical organizations. Recent Findings: No consensus exists on whether or not screening to prevent skin cancer is warranted. Summary: The best evidence of screening efficacy should come from population-based randomized trials, but is unlikely to exist due to feasibility constraints. Consequently, consensus should be built from observational/non-randomized designs, such as the SCREEN study in Germany. Current guidelines often focus on melanoma alone, while potential benefits of screening for non-melanoma skin cancers (NMSC) are largely overlooked. There may be less room for doubt regarding the value of screening, if both diseases were considered. Further, targeted approaches, i.e., screening only in high-risk populations, remain poorly defined and untested. Continuing to state that there is insufficient evidence to recommend screening leads to confusion about whether or not to screen and is unlikely to result in substantial changes to the morbidity of NMSC and significant mortality from melanoma.",
keywords = "Guidelines, Recommendations, Review, Screening, Skin cancer, Skin examination",
author = "Wojcik, {K. Y.} and Escobedo, {L. A.} and Miller, {K. A.} and M. Hawkins and O. Ahadiat and S. Higgins and Ashley Wysong and Myles Cockburn",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s13671-017-0205-6",
language = "English (US)",
volume = "6",
pages = "316--324",
journal = "Current Dermatology Reports",
issn = "2162-4933",
publisher = "Springer US",
number = "4",

}

TY - JOUR

T1 - Conflicts and Contradictions in Current Skin Cancer Screening Guidelines

AU - Wojcik, K. Y.

AU - Escobedo, L. A.

AU - Miller, K. A.

AU - Hawkins, M.

AU - Ahadiat, O.

AU - Higgins, S.

AU - Wysong, Ashley

AU - Cockburn, Myles

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Purpose of Review: The purpose of this paper is to review skin cancer screening guidelines from major public health/medical organizations. Recent Findings: No consensus exists on whether or not screening to prevent skin cancer is warranted. Summary: The best evidence of screening efficacy should come from population-based randomized trials, but is unlikely to exist due to feasibility constraints. Consequently, consensus should be built from observational/non-randomized designs, such as the SCREEN study in Germany. Current guidelines often focus on melanoma alone, while potential benefits of screening for non-melanoma skin cancers (NMSC) are largely overlooked. There may be less room for doubt regarding the value of screening, if both diseases were considered. Further, targeted approaches, i.e., screening only in high-risk populations, remain poorly defined and untested. Continuing to state that there is insufficient evidence to recommend screening leads to confusion about whether or not to screen and is unlikely to result in substantial changes to the morbidity of NMSC and significant mortality from melanoma.

AB - Purpose of Review: The purpose of this paper is to review skin cancer screening guidelines from major public health/medical organizations. Recent Findings: No consensus exists on whether or not screening to prevent skin cancer is warranted. Summary: The best evidence of screening efficacy should come from population-based randomized trials, but is unlikely to exist due to feasibility constraints. Consequently, consensus should be built from observational/non-randomized designs, such as the SCREEN study in Germany. Current guidelines often focus on melanoma alone, while potential benefits of screening for non-melanoma skin cancers (NMSC) are largely overlooked. There may be less room for doubt regarding the value of screening, if both diseases were considered. Further, targeted approaches, i.e., screening only in high-risk populations, remain poorly defined and untested. Continuing to state that there is insufficient evidence to recommend screening leads to confusion about whether or not to screen and is unlikely to result in substantial changes to the morbidity of NMSC and significant mortality from melanoma.

KW - Guidelines

KW - Recommendations

KW - Review

KW - Screening

KW - Skin cancer

KW - Skin examination

UR - http://www.scopus.com/inward/record.url?scp=85069328301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069328301&partnerID=8YFLogxK

U2 - 10.1007/s13671-017-0205-6

DO - 10.1007/s13671-017-0205-6

M3 - Review article

VL - 6

SP - 316

EP - 324

JO - Current Dermatology Reports

JF - Current Dermatology Reports

SN - 2162-4933

IS - 4

ER -